The American Cancer Society has shared its breast cancer expectations for 2024 and predicts over 310,000 patients will be diagnosed with invasive breast cancer and over 42,000 women will die because of the disease. The rate of breast cancer continues to increase in the United States with younger women experiencing a greater increase. Sixty-two is the average age for breast cancer diagnosis. 1 in 8 women will suffer from breast cancer at some time in their life1. To improve outcomes early diagnosis and treatment are key and new imaging modalities and blood biomarkers provide hope for increased sensitivity for detection with decreased false positives. The role of artificial intelligence has yet to be fully actualized but there is great hope that it could improve the diagnostic accuracy of available imaging modalities. Cutting-edge research could allow improved risk stratification leading ultimately to cancer prevention. This collection of articles will consider where we are now on the path to achieving these goals and what we will have to do to make them a reality. So many strides have been made and so much more work is yet to be done.
Possible topics for manuscripts submission:
•AI’s role in increasing the sensitivity and specificity of current imaging techniques.
•The role of serologic biomarkers “liquid biopsy” in the fight against breast cancer.
•Risk reduction strategies for breast cancer.
•Novel imaging techniques (i.e. Fast MRI, elastography, scintimammography).
•Risk stratification and chemoprevention.